What is Teva Pharmaceutical Industries Quick Ratio?
Teva Pharmaceutical IndustriesFRA:TEV +2.68%60 Quick Ratio is 0.78 as of Mar. 2026, which is 18% above its 10-year median of 0.66. GuruFocus rates FRA:TEV with a GF Score™ of 60/100 and a GF Value™ of €17.53 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 996 Drug Manufacturers companies, Teva Pharmaceutical Industries ranks worse than 76.91% on this metric.
Teva Pharmaceutical Industries has a quick ratio of 0.78. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Teva Pharmaceutical Industries's Quick Ratio or its related term are showing as below:
FRA:TEV'
s Quick Ratio Range Over the Past 10 Years
Min: 0.56 Med: 0.66 Max: 1
Current: 0.78
During the past 13 years, Teva Pharmaceutical Industries's highest Quick Ratio was 1.00. The lowest was 0.56. And the median was 0.66.
FRA:TEV's Quick Ratio is ranked worse than 76.91% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs FRA:TEV: 0.78
Teva Pharmaceutical Industries (FRA:TEV) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Teva Pharmaceutical Industries Quick Ratio Related Terms
Teva Pharmaceutical Industries Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:TEV vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teva Pharmaceutical Industries Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Teva Pharmaceutical Industries's Quick Ratio falls into.
Teva Pharmaceutical Industries Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teva Pharmaceutical Industries (FRA:TEV) has a Quick Ratio of 0.78 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Teva Pharmaceutical Industries and its competitors. This is 18% above median its historical median of 0.66. Over the past decade, Teva Pharmaceutical Industries' Quick Ratio has ranged from 0.56 to 1.00. According to the industry distribution chart, Teva Pharmaceutical Industries ranks #766 out of 996 companies in the Drug Manufacturers industry, placing it in the top 76.9%.
Is Teva Pharmaceutical Industries' Quick Ratio too high?
Teva Pharmaceutical Industries' current Quick Ratio of 0.78 is 18% above median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 1.00. The Drug Manufacturers industry median Quick Ratio is 1.45. Teva Pharmaceutical Industries' value of 0.78 is 46.2% below this industry median. Based on the distribution chart, Teva Pharmaceutical Industries ranks #766 out of 996 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Teva Pharmaceutical Industries has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Teva Pharmaceutical Industries' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Teva Pharmaceutical Industries ranks #766 out of 996 companies for Quick Ratio. This places Teva Pharmaceutical Industries in the lower half of its industry. The industry median Quick Ratio is 1.45. Teva Pharmaceutical Industries' value of 0.78 is 46.2% below this benchmark. Historically, Teva Pharmaceutical Industries' own Quick Ratio has ranged from 0.56 to 1.00 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 1.45, Teva Pharmaceutical Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teva Pharmaceutical Industries's current Quick Ratio of 0.78 is 46.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Teva Pharmaceutical Industries and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teva Pharmaceutical Industries's current Quick Ratio is 0.78, which is 18% above median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teva Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Teva Pharmaceutical Industries (FRA:TEV) is currently considered Significantly Overvalued. The stock's GF Value™ is €17.53, compared to a current price of €30.60 — trading 74.6% above its estimated fair value. The current Quick Ratio is 0.78, which is 18% above median its 10-year median of 0.66 and 46.2% below the Drug Manufacturers industry median of 1.45. Teva Pharmaceutical Industries' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Teva Pharmaceutical Industries (FRA:TEV), the current Quick Ratio is 0.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teva Pharmaceutical Industries (FRA:TEV) Overvalued in 2026?
Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued.
The current stock price of €30.60 is trading 74.6% above its estimated GF Value™ of €17.53.
GuruFocus considers Teva Pharmaceutical Industries to be Significantly Overvalued.
Key valuation signals for FRA:TEV:
Quick Ratio: 0.78 (18% above median its 10-year median of 0.66)
GF Value™: €17.53 vs. price of €30.60 (74.6% above fair value)
Industry Position: 46.2% below the Drug Manufacturers median (#766 of 996)
No single metric tells the full story. See the FRA:TEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teva Pharmaceutical Industries Business Description
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
60GF Score
Get the complete analysis for FRA:TEV
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TEV has been successfully added to your 
